Patent applications and USPTO patent grants for Millan; Mark.The latest application filed is for "use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd)".
Patent | Date |
---|---|
Use Of Agomelatine In Obtaining Medicaments Intended For The Treatment Of Obsessive-compulsive Disorder (ocd) App 20120309838 - Laigle; Laurence ;   et al. | 2012-12-06 |
Chromene compounds, a process for their preparation and pharmaceutical compositions containing them Grant 8,247,441 - De Nanteuil , et al. August 21, 2 | 2012-08-21 |
Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder Grant 7,960,438 - Delalleau , et al. June 14, 2 | 2011-06-14 |
Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them Grant 7,947,852 - Yous , et al. May 24, 2 | 2011-05-24 |
Chromene compounds, a process for their preparationand pharmaceutical compositions containing them App 20110021490 - De Nanteuil; Guillaume ;   et al. | 2011-01-27 |
Naphthalene Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20100168244 - Yous; Said ;   et al. | 2010-07-01 |
Naphthalene Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20100137446 - Yous; Said ;   et al. | 2010-06-03 |
Piperazine compounds Grant 7,612,061 - Peglion , et al. November 3, 2 | 2009-11-03 |
Piperazine compounds App 20090076030 - Peglion; Jean-Louis ;   et al. | 2009-03-19 |
Piperazine compounds App 20090075982 - Peglion; Jean-Louis ;   et al. | 2009-03-19 |
Tetracyclic compounds Grant 7,470,683 - Peglion , et al. December 30, 2 | 2008-12-30 |
Piperazine compounds Grant 7,465,733 - Peglion , et al. December 16, 2 | 2008-12-16 |
Naphthalene compounds Grant 7,462,741 - Yous , et al. December 9, 2 | 2008-12-09 |
Indanyl-piperazine compounds Grant 7,442,692 - De Nanteuil , et al. October 28, 2 | 2008-10-28 |
Naphthalene compounds Grant 7,435,850 - Yous , et al. October 14, 2 | 2008-10-14 |
Tetracyclic compounds App 20080076765 - Peglion; Jean-Louis ;   et al. | 2008-03-27 |
Naphthalene compounds App 20080004350 - Yous; Said ;   et al. | 2008-01-03 |
Naphthalene compounds App 20080004349 - Yous; Said ;   et al. | 2008-01-03 |
Use of agomelatine in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder App 20070238792 - Delalleau; Bruno ;   et al. | 2007-10-11 |
Piperazine compounds App 20060229318 - Peglion; Jean-Louis ;   et al. | 2006-10-12 |
Indanyl-piperazine compounds App 20060223830 - De Nanteuil; Guillaume ;   et al. | 2006-10-05 |
Indoline compounds Grant 7,053,108 - Lavielle , et al. May 30, 2 | 2006-05-30 |
Diphenylurea compounds Grant 7,026,357 - Lavielle , et al. April 11, 2 | 2006-04-11 |
Benzoindoline compounds Grant 6,998,403 - Lavielle , et al. February 14, 2 | 2006-02-14 |
Benzoindoline compounds App 20050059675 - Lavielle, Gilbert ;   et al. | 2005-03-17 |
Diphenylurea compounds App 20040224993 - Lavielle, Gilbert ;   et al. | 2004-11-11 |
New indoline compounds App 20040192736 - Lavielle, Gilbert ;   et al. | 2004-09-30 |
Diphenylurea compounds Grant 6,784,183 - Lavielle , et al. August 31, 2 | 2004-08-31 |
Indoline compounds, a process for their preparation and pharmaceutical compositions containing them Grant 6,759,421 - Lavielle , et al. July 6, 2 | 2004-07-06 |
Pyrimidin-4-one compounds Grant 6,747,032 - Lavielle , et al. June 8, 2 | 2004-06-08 |
Cyclobutaindolecarboxamide compounds Grant 6,743,818 - Peglion , et al. June 1, 2 | 2004-06-01 |
Indoline compounds and to pharmaceutical compositions containing them App 20030199555 - Lavielle, Gilbert ;   et al. | 2003-10-23 |
Pyrimidin-4-one compounds App 20030087916 - Lavielle, Gilbert ;   et al. | 2003-05-08 |
Cyclobutaindolecarboxamide compounds App 20030032812 - Peglion, Jean-Louis ;   et al. | 2003-02-13 |
Piperidine compounds App 20020161228 - Peglion, Jean Louis ;   et al. | 2002-10-31 |
Diphenylurea compounds App 20020025965 - Lavielle, Gilbert ;   et al. | 2002-02-28 |
Beta-carboline compounds Grant 6,350,757 - Goldstein , et al. February 26, 2 | 2002-02-26 |
Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds App 20020019380 - Peglion, Jean-Louis ;   et al. | 2002-02-14 |
Cyclobutaindolecarboxamide compounds App 20010044426 - Peglion, Jean-Louis ;   et al. | 2001-11-22 |
Cyano-indole serotonin-reuptake inhibitor compounds Grant 6,239,129 - Lavielle , et al. May 29, 2 | 2001-05-29 |
Substituted hydrochromenopyrroles Grant 6,090,837 - Lavielle , et al. July 18, 2 | 2000-07-18 |
Indanol compounds Grant 5,958,927 - Peglion , et al. September 28, 1 | 1999-09-28 |
3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds Grant 5,780,474 - Peglion , et al. July 14, 1 | 1998-07-14 |
Indole, indazole and benzisoxazole compounds Grant 5,703,070 - Lavielle , et al. December 30, 1 | 1997-12-30 |
New benzodioxane compounds Grant 5,500,443 - Lavielle , et al. March 19, 1 | 1996-03-19 |
N-substituted N'-heterobicyclic piperazines having pharmaceutical activity Grant 5,464,834 - Peglion , et al. November 7, 1 | 1995-11-07 |
1,4-disubstituted piperazines Grant 5,194,437 - Peglion , et al. March 16, 1 | 1993-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.